See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Mario Plaas

https://www.etis.ee/CV/Mario_Plaas/est
29.09.1980
502 3056
mario.plaas@ut.ee

Teenistuskäik

Töökohad ja ametid
01.01.2014–...   
Tartu Ülikool, Bio- ja Siirdemeditsiini Instituudi Katseloomakeskuse juhataja (1,00)
2008–28.02.2014   
Eesti Maaülikool, Veterinaarmeditsiini ja loomakasvatuse instituut, Teadur (0,50)
20.06.2005–31.12.2013   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, transgeense tehnoloogia laborijuhataja (1,00)
01.01.2004–31.12.2005   
OÜ Naxo, transgeneetika spetsialist
01.01.2003–31.12.2005   
OÜ Visgenyx, mikroinjekteerija
 
 
Haridustee
2005–2013   
Tartu Ülikool , Arengubioloogia doktoriõpe
2003–2005   
2005 Tartu Ülikool MSc Arengubioloogias
1999–2003   
Tartu Ülikool Bakalaureuse kraad geenitehnoloogias
1996–1999   
Haapsalu Gümnaasium, keskharidus

Kvalifikatsioon

Teaduskraadid
Mario Plaas, doktorikraad, 2013, (juh) Sulev Kõks; Alar Karis; Eero Vasar, Animal model of Wolfram Syndrome in mice: behavioural, biochemical and psychopharmacological characterization (Wolframi sündroomi mudel hiirtel: käitumuslik, biokeemiline ja psühhofarmakoloogiline iseloomustamine), Tartu Ülikool, Loodus- ja tehnoloogiateaduskond.
Mario Plaas, magistrikraad (teaduskraad), 2005, (juh) Sulev Kõks; Raivo Raid, Alfa-SYN Ala30Pro punktmutatsiooniga ja beeta-SYN deletsiooniga transgeensete hiirte loomine: uued Parkinsoni tõve mudelid, Tartu Ülikool, Bioloogia-geograafiateaduskond, Zooloogia ja hüdrobioloogia instituut.
 
 
Teaduspreemiad ja tunnustused
2011, Mario Plaas, U.S. Saatkond, Baltic American Freedom Foundation (BAFF) ja American Chamber of Commerce in Estonia (AmCham) valisid osaühingu KPA Scientific 6 ettevõtte hulka, kes teevad aktiivselt innovatsiooni Ameerika Ühendriikidega
2011, Mario Plaas, 3 koht Eesti suurimal äriplaani konkursil "Ajujaht" . "Geneetiliselt humaniseeritud loommudelid Hepatiidi viirus C ravimiarenduseks".
2006, Mario Plaas, Nets prize for the bisnes plan of running the transgenic tehnology laboratory
2006, Mario Plaas, Nets ettevõtlus programmi raames pälvisin eripreemia transgeense tehnoloogia labori äriplaani eest
 
 
Teadustöö põhisuunad
VALDKOND: 1. Bio- ja keskkonnateadused; 1.3. Geneetika
VALDKOND: 3. Terviseuuringud; 3.1. Biomeditsiin

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2017
Plaas, Mario; Seppa, Kadri; Reimets, Riin; Jagomäe, Toomas; Toots, Maarja; Koppel, Tuuliki; Vallisoo, Tuuli; Nigul, Mait; Heinla, Indrek; Meier, Riho; Kaasik, Allen; Piirsoo, Andres; Hickey, Miriam A.; Terasmaa, Anton; Vasar, Eero (2017). Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration. Scientific Reports, 7 (10220).s41598-017-09392-x.
1.1.
2016
Krjutškov, Kaarel; Koel, Mariann; Roost, Anne Mari; Katayama, Shintaro; Einarsdottir, Elisabet; Jouhilahti, Eeva-Mari; Söderhäll, Cilla; Jaakma, Ülle; Plaas, Mario; Vesterlund, Liselotte; Lohi, Hannes; Salumets, Andres; Kere, Juha (2016). Globin mRNA reduction for whole-blood transcriptome sequencing. Scientific Reports, 6, 31584−31584.10.1038/srep31584.
1.1.
2016
Sedman, Tuuli; Rünkorg, Kerttu; Krass, Maarja; Luuk, Hendrik; Plaas, Mario; Vasar Eero; Volke, Vallo (2016). Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1. Journal of Diabetes Research, 9239530, 1−7.10.1155/2016/9239530.
1.1.
2014
Rebane, Ana; Runnel, Toomas; Aab, Alar; Maslovskaja, Julia; Rückert, Beate; Zimmermann, Maya; Plaas, Mario; Kärner, Jaanika; Treis, Angela; Pihlap, Maire; Haljasorg, Uku; Hermann, Helen; Nagy, Nikoletta; Kemeny, Lajos; Erm, Triin; Kingo, Külli; Li, Mei; Boldin, Mark P; Akdis, Cezmi A (2014). MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. The Journal of Allergy and Clinical Immunology, 134 (4), 836−847.e11.10.1016/j.jaci.2014.05.022.
1.1.
2013
Visnapuu, T.; Plaas, M.; Reimets, R.; Raud, S.; Terasmaa, A.; Kõks, S.; Sütt, S.; Luuk, H.; Hundahl, C.A.; Eskla, K.-L.; Altpere, A.; Alttoa, A.; Harro, J.; Vasar, E. (2013). Evidence for impaired function of dopaminergic system in Wfs1-deficient mice. Behavioural Brain Research, 244, 90−99.10.1016/j.bbr.2013.01.046.
1.2.
2013
Visnapuu, T.; Raud, S.; Loomets, M.; Reimets, R.: Sütt, S.; Luuk, H.; Plaas, M.; Kõks, S.; Volke, V.; Alttoa, A.; Harro, J.; Vasar, E. (2013). Wfs1-deficient mice display altered function of serotonergic system and increased behavioural response to antidepressants. Frontiers in Neuroscience, 7 (132), 1−8.10.3389/fnins.2013.00132.
5.1.
2013
Parn, Pille; Plaas, Mario; Nomm, Monika; Jaakma, Ulle; Koks, Sulev. (2013). EFFECTS OF CULTURE CONDITIONS AND GENE TRANSFECTION ON THE DEVELOPMENT OF BOVINE SOMATIC CELL NUCLEAR TRANSFER EMBRYOS. REPRODUCTION FERTILITY AND DEVELOPMENT, 25: IETS, Hannover, Germany, January 19-22, 2013. CSIRO PUBLISHING, 172−172.
1.1.
2012
Örd, Tiit; Örd, Daima; Kuuse, Sulev; Plaas, Mario; Örd, Tõnis (2012). Trib3 is regulated by IL-3 and affects bone marrow-derived mast cell survival and function. Cellular Immunology, 280, 68−75.
1.1.
2011
Kõks, S.; Soomets, U.; Plaas, M.; Terasmaa, A.; Noormets, K.; Tillmann, V.; Vasar, E.; Fernandes, C.; Schalkwyk, LC. (2011). Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice. Physiological genomics, 43, 1351−1358.10.1152/physiolgenomics.00117.2011.
1.1.
2011
Innos, J.; Philips, M.-A.; Leidmaa, E.; Heinla, I.; Raud, S.; Reemann, P.; Plaas, M.; Nurk, K.; Kurrikoff, K.; Matto, V.; Visnapuu, T.; Mardi, P.; Kõks, S.; Vasar, E. (2011). Lower anxiety and a decrease in agonistic behaviour in Lsamp-deficient mice. Behavioural Brain Research, 217 (1), 21−31.10.1016/j.bbr.2010.09.019.
1.1.
2010
Sütt, S.; Raud, S.; Abramov, U.; Innos, J.; Luuk, H.; Plaas, M.; Kõks, S.; Zilmer, K.; Mahlapuu, R.; Zilmer, M.; Vasar, E. (2010). Relation of exploratory behaviour to plasma corticosterone and Wfs1 gene expression in Wistar rats. Journal of Psychopharmacology, 24 (6), 905−913.10.1177/0269881109102738.
1.1.
2010
Philips, M.-A.; Abramov, U.; Lilleväli, K; Luuk, H.; Kurrikoff, K.; Raud, S.; Plaas, M.; Innos, J.; Puussaar, T.; Kõks, S.; Vasar, E. (2010). Myg1-deficent mice display alterations in stress-inducedresponses and reduction of sex-dependent behavioural differences. Behavioural Brain Research, 207 (1), 182−195.10.1016/j.bbr.2009.10.005.
1.1.
2009
Raud, S.; Sütt, S.; Luuk, H.; Plaas, M.; Innos, J.; Kõks, S.; Vasar, E. (2009). Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits GABA(A) receptors in Wfs1-deficient mice. Neuroscience Letters, 460 (2), 138−142.10.1016/j.neulet.2009.05.054.
1.1.
2009
Koks, S.; Soomets, U.; Paya-Cano, J.; Fernandes, C.; Luuk, H.; Plaas, M.; Terasmaa, A.; Tillmann, V.; Noormets, K.; Vasar, E.; Schalkwyk, LC. (2009). Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiological genomics, 37, 3, 249−259.
1.1.
2009
Luuk, H.; Plaas, M.; Raud, S.; Innos, J.; Sütt, S.; Lasner, H.; Abramov, U.; Kurrikoff, K.; Kõks, S.; Vasar, E. (2009). Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behavioural Brain Research, 198 (2), 334−345.10.1016/j.bbr.2008.11.007.
5.1.
2009
Asser, A.; Kõks, S.; Haaparanta-Solin, M.; Grönroos, T.; Pakkanen, A.; Nairismägi, J.; Plaas, M.; Sauk, M.; Piip, P.; Eltermaa, M.; Lindmäe, H.; Taba, P. (2009). The effects of chronic administration of ephedrone (methcathinone) and manganese in mice. Movement Disorders, 24, S48−S49.
1.1.
2008
Luuk, H.; Koks, S.; Plaas, M.; Hannibal, J.; Rehfeld, JF.; Vasar, E. (2008). Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome. Journal of Comparative Neurology, 509 (6), 642−660.10.1002/cne.21777.
1.1.
2008
Plaas, M.; Karis, A.; Innos, J.; Rebane, E.; Baekelandt, V.; Vaarmann, A.; Luuk, H.; Vasar, E.; Koks, S. (2008). Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice. Journal of Physiology and Pharmacology, 59 (2), 205−216.
1.1.
2007
Raud, S.; Sütt, S.; Plaas, M.; Luuk, H.; Innos, J.; Philips, M.A.; Kõks, S.; Vasar, E. (2007). Cat odor exposure induces distinct changes in the exploratory behavior and Wfs1 gene expression in C57Bl/6 and 129Sv mice. Neuroscience Letters, 426 (2), 87−90.10.1016/j.neulet.2007.08.052.
1.3.
2007
Philips, M.-A.; Luuk, H.; Heinla, I.; Plaas, M.; Kõks, S.; Vasar, E. (2007). LSAMP valku ekspresseerivad neuronid hiire kesknärvisüsteemis ei paikne üksnes limbilises süsteemis, vaid ka sensoorsetes süsteemides. Eesti Arst, 9, 700−701.
1.1.
2006
Tonissoo, T.; Koks, S.; Meier, R.; Raud, S.; Plaas, M.; Vasar, E.; Karis, A. (2006). Heterozygous mice with Ric-8 mutation exhibit impaired spatial memory and decreased anxiety. Behavioural Brain Research, 167 (1), 42−48.
5.2.
2004
Kõks, S.; Raud, S.; Kurrikoff, K.; Veraksitš, A.; Plaas, M.; Reimets, A.; Aunapuu, M.; Vasar, E. (2004). Koletsüstokiniini ajuspetsiifiline üleekspressioon hiirtel suurendab ärevust ja tundlikkust morfiini antiotsitseptiivse toime suhtes. Eesti Arst, 9, 599.
1.1.
2003
Tonissoo, T.; Meier, R.; Talts, K.; Plaas, M.; Karis, A. (2003). Expression of ric-8 (synembryn) gene in the nervous system of developing and adult mouse. Gene Expression Patterns, 3 (5), 591−594.

Tööstusomand

Mario Plaas

https://www.etis.ee/CV/Mario_Plaas/eng
29.09.1980
502 3056
mario.plaas@ut.ee

Career

Institution and occupation
01.01.2014–...   
University of Tartu, Other staff (1,00)
2008–28.02.2014   
Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences, Researcher (0,50)
20.06.2005–31.12.2013   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, transgeense tehnoloogia laborijuhataja (1,00)
01.01.2004–31.12.2005   
OÜ Naxo, Specialist of transgenic tehnology
01.01.2003–31.12.2005   
OÜ Visgenyx, microinjectionist
 
 
Education
2005–2013   
Univesity of Tartu, Phd, developmental biology
2003–2005   
Univesity of Tartu, MSc degree, developmental biology
1999–2003   
Univesity of Tartu, BSc degree, genetehnology
1996–1999   
Haapsalu gymnasium

Qualifications

Academic degrees
Mario Plaas, Doctor's Degree, 2013, (sup) Sulev Kõks; Alar Karis; Eero Vasar, Animal model of Wolfram Syndrome in mice: behavioural, biochemical and psychopharmacological characterization, University of Tartu, Faculty of Science and Technology (old).
Mario Plaas, Master's Degree, 2005, (sup) Sulev Kõks; Raivo Raid, Alfa-SYN Ala30Pro punktmutatsiooniga ja beeta-SYN deletsiooniga transgeensete hiirte loomine: uued Parkinsoni tõve mudelid (Mutant mouse lines with alpha-syn Ala30Pro point-mutation and beta-syn deletion as new models for Parkinson disorder), University of Tartu, Faculty of Biology and Geography, Institute of Zoology and Hydrobiology.
 
 
Honours & awards
2011, Mario Plaas, The U.S. Embassy, the Baltic American Freedom Foundation (BAFF), and the American Chamber of Commerce in Estonia (AmCham) selected KPA Scientific OÜ to the six finalists for the 2011 Estonian American Innovation Award.
2011, Mario Plaas, 3 place in Estonian business plan contest called “Brain storm”. Hepatitis Virus C infectable small animal models
2006, Mario Plaas, Nets prize for the bisnes plan of running the transgenic tehnology laboratory
2006, Mario Plaas, Nets ettevõtlus programmi raames pälvisin eripreemia transgeense tehnoloogia labori äriplaani eest
 
 
Field of research
FIELD OF RESEARCH: 1. Biosciences and Environment; 1.3. Genetics
FIELD OF RESEARCH: 3. Health; 3.1. Biomedicine
 
 

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2017
Plaas, Mario; Seppa, Kadri; Reimets, Riin; Jagomäe, Toomas; Toots, Maarja; Koppel, Tuuliki; Vallisoo, Tuuli; Nigul, Mait; Heinla, Indrek; Meier, Riho; Kaasik, Allen; Piirsoo, Andres; Hickey, Miriam A.; Terasmaa, Anton; Vasar, Eero (2017). Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration. Scientific Reports, 7 (10220).s41598-017-09392-x.
1.1.
2016
Krjutškov, Kaarel; Koel, Mariann; Roost, Anne Mari; Katayama, Shintaro; Einarsdottir, Elisabet; Jouhilahti, Eeva-Mari; Söderhäll, Cilla; Jaakma, Ülle; Plaas, Mario; Vesterlund, Liselotte; Lohi, Hannes; Salumets, Andres; Kere, Juha (2016). Globin mRNA reduction for whole-blood transcriptome sequencing. Scientific Reports, 6, 31584−31584.10.1038/srep31584.
1.1.
2016
Sedman, Tuuli; Rünkorg, Kerttu; Krass, Maarja; Luuk, Hendrik; Plaas, Mario; Vasar Eero; Volke, Vallo (2016). Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1. Journal of Diabetes Research, 9239530, 1−7.10.1155/2016/9239530.
1.1.
2014
Rebane, Ana; Runnel, Toomas; Aab, Alar; Maslovskaja, Julia; Rückert, Beate; Zimmermann, Maya; Plaas, Mario; Kärner, Jaanika; Treis, Angela; Pihlap, Maire; Haljasorg, Uku; Hermann, Helen; Nagy, Nikoletta; Kemeny, Lajos; Erm, Triin; Kingo, Külli; Li, Mei; Boldin, Mark P; Akdis, Cezmi A (2014). MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. The Journal of Allergy and Clinical Immunology, 134 (4), 836−847.e11.10.1016/j.jaci.2014.05.022.
1.1.
2013
Visnapuu, T.; Plaas, M.; Reimets, R.; Raud, S.; Terasmaa, A.; Kõks, S.; Sütt, S.; Luuk, H.; Hundahl, C.A.; Eskla, K.-L.; Altpere, A.; Alttoa, A.; Harro, J.; Vasar, E. (2013). Evidence for impaired function of dopaminergic system in Wfs1-deficient mice. Behavioural Brain Research, 244, 90−99.10.1016/j.bbr.2013.01.046.
1.2.
2013
Visnapuu, T.; Raud, S.; Loomets, M.; Reimets, R.: Sütt, S.; Luuk, H.; Plaas, M.; Kõks, S.; Volke, V.; Alttoa, A.; Harro, J.; Vasar, E. (2013). Wfs1-deficient mice display altered function of serotonergic system and increased behavioural response to antidepressants. Frontiers in Neuroscience, 7 (132), 1−8.10.3389/fnins.2013.00132.
5.1.
2013
Parn, Pille; Plaas, Mario; Nomm, Monika; Jaakma, Ulle; Koks, Sulev. (2013). EFFECTS OF CULTURE CONDITIONS AND GENE TRANSFECTION ON THE DEVELOPMENT OF BOVINE SOMATIC CELL NUCLEAR TRANSFER EMBRYOS. REPRODUCTION FERTILITY AND DEVELOPMENT, 25: IETS, Hannover, Germany, January 19-22, 2013. CSIRO PUBLISHING, 172−172.
1.1.
2012
Örd, Tiit; Örd, Daima; Kuuse, Sulev; Plaas, Mario; Örd, Tõnis (2012). Trib3 is regulated by IL-3 and affects bone marrow-derived mast cell survival and function. Cellular Immunology, 280, 68−75.
1.1.
2011
Kõks, S.; Soomets, U.; Plaas, M.; Terasmaa, A.; Noormets, K.; Tillmann, V.; Vasar, E.; Fernandes, C.; Schalkwyk, LC. (2011). Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice. Physiological genomics, 43, 1351−1358.10.1152/physiolgenomics.00117.2011.
1.1.
2011
Innos, J.; Philips, M.-A.; Leidmaa, E.; Heinla, I.; Raud, S.; Reemann, P.; Plaas, M.; Nurk, K.; Kurrikoff, K.; Matto, V.; Visnapuu, T.; Mardi, P.; Kõks, S.; Vasar, E. (2011). Lower anxiety and a decrease in agonistic behaviour in Lsamp-deficient mice. Behavioural Brain Research, 217 (1), 21−31.10.1016/j.bbr.2010.09.019.
1.1.
2010
Sütt, S.; Raud, S.; Abramov, U.; Innos, J.; Luuk, H.; Plaas, M.; Kõks, S.; Zilmer, K.; Mahlapuu, R.; Zilmer, M.; Vasar, E. (2010). Relation of exploratory behaviour to plasma corticosterone and Wfs1 gene expression in Wistar rats. Journal of Psychopharmacology, 24 (6), 905−913.10.1177/0269881109102738.
1.1.
2010
Philips, M.-A.; Abramov, U.; Lilleväli, K; Luuk, H.; Kurrikoff, K.; Raud, S.; Plaas, M.; Innos, J.; Puussaar, T.; Kõks, S.; Vasar, E. (2010). Myg1-deficent mice display alterations in stress-inducedresponses and reduction of sex-dependent behavioural differences. Behavioural Brain Research, 207 (1), 182−195.10.1016/j.bbr.2009.10.005.
1.1.
2009
Raud, S.; Sütt, S.; Luuk, H.; Plaas, M.; Innos, J.; Kõks, S.; Vasar, E. (2009). Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits GABA(A) receptors in Wfs1-deficient mice. Neuroscience Letters, 460 (2), 138−142.10.1016/j.neulet.2009.05.054.
1.1.
2009
Koks, S.; Soomets, U.; Paya-Cano, J.; Fernandes, C.; Luuk, H.; Plaas, M.; Terasmaa, A.; Tillmann, V.; Noormets, K.; Vasar, E.; Schalkwyk, LC. (2009). Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiological genomics, 37, 3, 249−259.
1.1.
2009
Luuk, H.; Plaas, M.; Raud, S.; Innos, J.; Sütt, S.; Lasner, H.; Abramov, U.; Kurrikoff, K.; Kõks, S.; Vasar, E. (2009). Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behavioural Brain Research, 198 (2), 334−345.10.1016/j.bbr.2008.11.007.
5.1.
2009
Asser, A.; Kõks, S.; Haaparanta-Solin, M.; Grönroos, T.; Pakkanen, A.; Nairismägi, J.; Plaas, M.; Sauk, M.; Piip, P.; Eltermaa, M.; Lindmäe, H.; Taba, P. (2009). The effects of chronic administration of ephedrone (methcathinone) and manganese in mice. Movement Disorders, 24, S48−S49.
1.1.
2008
Luuk, H.; Koks, S.; Plaas, M.; Hannibal, J.; Rehfeld, JF.; Vasar, E. (2008). Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome. Journal of Comparative Neurology, 509 (6), 642−660.10.1002/cne.21777.
1.1.
2008
Plaas, M.; Karis, A.; Innos, J.; Rebane, E.; Baekelandt, V.; Vaarmann, A.; Luuk, H.; Vasar, E.; Koks, S. (2008). Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice. Journal of Physiology and Pharmacology, 59 (2), 205−216.
1.1.
2007
Raud, S.; Sütt, S.; Plaas, M.; Luuk, H.; Innos, J.; Philips, M.A.; Kõks, S.; Vasar, E. (2007). Cat odor exposure induces distinct changes in the exploratory behavior and Wfs1 gene expression in C57Bl/6 and 129Sv mice. Neuroscience Letters, 426 (2), 87−90.10.1016/j.neulet.2007.08.052.
1.3.
2007
Philips, M.-A.; Luuk, H.; Heinla, I.; Plaas, M.; Kõks, S.; Vasar, E. (2007). LSAMP valku ekspresseerivad neuronid hiire kesknärvisüsteemis ei paikne üksnes limbilises süsteemis, vaid ka sensoorsetes süsteemides. Eesti Arst, 9, 700−701.
1.1.
2006
Tonissoo, T.; Koks, S.; Meier, R.; Raud, S.; Plaas, M.; Vasar, E.; Karis, A. (2006). Heterozygous mice with Ric-8 mutation exhibit impaired spatial memory and decreased anxiety. Behavioural Brain Research, 167 (1), 42−48.
5.2.
2004
Kõks, S.; Raud, S.; Kurrikoff, K.; Veraksitš, A.; Plaas, M.; Reimets, A.; Aunapuu, M.; Vasar, E. (2004). Koletsüstokiniini ajuspetsiifiline üleekspressioon hiirtel suurendab ärevust ja tundlikkust morfiini antiotsitseptiivse toime suhtes. Eesti Arst, 9, 599.
1.1.
2003
Tonissoo, T.; Meier, R.; Talts, K.; Plaas, M.; Karis, A. (2003). Expression of ric-8 (synembryn) gene in the nervous system of developing and adult mouse. Gene Expression Patterns, 3 (5), 591−594.

Industrial property